Clinical Trial Update: Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A phase 1 trial evaluating cediranib maleate in combination with whole-brain radiation therapy for brain metastases in non-small cell lung cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Stage IV Breast Cancer | Phase 1 | Status: TERMINATED